Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Glyxambi 25mg/5mg tablets (Boehringer Ingelheim Ltd) |
| BNF code | 0601023AYBBABAB |
| Virtual Medicinal Product | Empagliflozin 25mg / Linagliptin 5mg tablets |
| Name | Glyxambi 25mg/5mg tablets |
| Supplier | Boehringer Ingelheim Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Oral |
| Actual Medicinal Product Packs | |
| Glyxambi 25mg/5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.